公司資料
Fulgent Genetics, Inc. 股價、新聞與催化劑
- 股票代碼:
- FLGT
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
18.66 USD (+0.54%)
收盤價
最後更新: 2026年8月17日
531M USD
市值
股價為何變動
As of Aug 17, 2026, FLGT closed up 0.54% at $18.66. No new same-company headline was identified in the current news window.
公司概覽
Precision Medicine Business
Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio. The company aims to combine diagnostic capabilities with drug development to become an integrated precision-medicine organization.
Laboratory Services
Fulgent provides technical laboratory testing and physician interpretation services. Its operations include genetic and specialty diagnostic capabilities serving healthcare providers, institutions and other customers.
Oncology Therapeutics
The therapeutic business uses nanoencapsulation and targeted-delivery technology to improve the pharmacokinetics and therapeutic window of cancer drugs. Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.
未來催化劑
- Phase 2 FID-007 data in a rapid oral presentation at the 2026 ASCO Annual Meeting.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。